Delivery Order SPE2DX15D3003-SPE2DX23F5Q1D
- Not listed
- The Defense Logistics Agency awarded a $32,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 boxes containing 2.5 mg tablets of Letrozole, an aromatase inhibitor used as a breast cancer treatment. To be performed under contract at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, the order requires delivery by August 28, 2023 to support the DLA's medical supply needs. No subcontractors or set aside designations were indicated. The...
- The Defense Logistics Agency Troop Support Medical awarded a $5,625.06 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 30 tablets of 2.5 mg Letrozole, a breast cancer medication. The prime contractor will fulfill the order from its Conshohocken, Pennsylvania facility by August 1, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified in the award information. The delivery order was issued...
- The Defense Logistics Agency awarded a $98,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 packages containing 2.5 mg tablets of Letrozole, an aromatase inhibitor used to treat breast cancer. The order was placed under an existing prime vendor contract vehicle and will be fulfilled from Amerisourcebergen's distribution center located in Conshohocken, Pennsylvania. Performance is required between August 21-22, 2023. No subcontractors or set aside...
- The Defense Logistics Agency Troop Support Medical awarded a $648 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 90 tablets of 2.5 mg Letrozole each. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle to provide pharmaceutical products and services in support of DOD medical readiness programs. Performance will take place in Conshohocken, Pennsylvania over a three-day period concluding on September 18, 2023. Pricing is...
- The Defense Logistics Agency awarded a $275,860 firm fixed price delivery order to AmerisourceBergen Drug Corporation for the supply of 90 tablets of 2.5 mg Letrozole, an aromatase inhibitor used to treat breast cancer. The order was placed under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, with delivery...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately one thousand fifty-eight dollars and thirty-six cents to Amerisourcebergen Drug Corporation for ninety tablets of the two and a half milligram strength of the breast cancer drug letrozole. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between September fourteenth and fifteenth of twenty twenty-three. The prime...
- The Defense Logistics Agency awarded a $3,458 delivery order to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 2.5 mg Letrozole, an aromatase inhibitor used to treat breast cancer. The firm fixed price order is being fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania for delivery between August 30 and August 31, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the military...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $47,500 to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 2.5 mg Letrozole, a breast cancer medication. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements under the delivery order. No major subcontractors or set aside designations were indicated. This order is consistent...
- The Defense Logistics Agency (DLA) awarded a $1,145.15 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30. The contract, which is a firm fixed price delivery order with no set-aside designation, is scheduled for completion by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement action and reflects AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,224.10 to AmerisourceBergen Drug Corp for the supply of Letrozole 2.5 mg tablets in a 90-count package. This competitive award, issued on August 11, 2025, with a completion date of August 12, 2025, represents a firm fixed price delivery order with no set-aside designation. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- SPE2DX15D3003Indefinite Delivery Contract
- SPE2DX15D3003-SPE2DX23F5Q1DDelivery Order
The Defense Logistics Agency Troop Support Medical awarded a $370.97 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 90 tablets of 2.5 mg Letrozole, an aromatase inhibitor used to treat breast cancer. The place of performance is Conshohocken, Pennsylvania. The delivery order period of performance is from July 31, 2023 through August 1, 2023 under the DLA's Prime Vendor Program indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set aside designations were identified. The brief period of performance and product description indicate this delivery order supports DLA's mission to provide critical pharmaceuticals to the Military Health System for its medical treatment programs on a just-in-time basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $371 | 7/31/23 |